Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers

Laurent Lam,Helene Fontaine,Nathanaël Lapidus,Celine Dorival,Jonathan Bellet,Dominique Larrey,Pierre Nahon,Alpha Diallo,Carole Cagnot,Clovis Lusivka-Nzinga,François Teoule,Gilles Hejblum,Marc Bourliere,Stanislas Pol,Fabrice Carrat

Journal of Hepatology（2022）

引用 4|浏览26

暂无评分

摘要

DAAs were not associated with extrahepatic cancer development or reduction. They were associated with a decreased risk of PAD and an increased risk of ACD, supporting long-term cardiac monitoring after DAA therapy. This article is protected by copyright. All rights reserved.

查看译文

关键词

Adverse events,Extrahepatic manifestations,Hepatitis C virus,Oral direct antiviral agents,SNDS

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要